A Novel System for Transcatheter Closure of Patent Foramen Ovale: Clinical and Echocardiographic Outcome Comparison With Other Contemporary Devices

被引:8
作者
Darsaklis, Konstadina [1 ]
Freixa, Xavier [1 ]
Asgar, Anita [1 ]
Ibrahim, Reda [1 ]
Basmadjian, Arsene [1 ]
DeGuise, Pierre [1 ]
Garceau, Patrick [1 ]
机构
[1] Univ Montreal, Montreal Heart Inst, Dept Cardiol, Montreal, PQ, Canada
关键词
ATRIAL SEPTAL ANEURYSM; PERCUTANEOUS CLOSURE; PARADOXICAL EMBOLISM; MEDICAL THERAPY; CRYPTOGENIC STROKE; FIBRILLATION; PREVENTION; AMPLATZER; EFFICACY; EVENTS;
D O I
10.1016/j.cjca.2014.03.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Effective closure performance for patent foramen ovale (PFO) has been suggested to be one of the factors that plays a relevant role in future clinical outcomes after stroke or transient ischemic attack. Methods: Between January 2009 and June 2012, all consecutive patients undergoing transcatheter PFO closure in our institution using the Amplatzer PFO Occluder (APO) (St Jude Medical, St Paul, MN), BioSTAR (NMT Medical Inc, Boston, MA), GORE HELEX (HELEX) (W.L. Gore & Associates, Newark, DE), and GORE Septal Occluder (GSO) (W.L. Gore & Associates) were included. Closure performance was assessed using transesophageal echocardiography 4 months after the index procedure. Results: One hundred ninety-three patients were included in the study. Patient distribution was as follows: (1) 48 GSO (24.8%); (2) 34 HELEX (17.6%); (3) 74 APO (38.3%); and (4) 37 BioSTAR (19.1%). No complications occurred during device implantation. During clinical follow-up (20.8 +/- 13.2 months), 2 (1.1%) patients had a stroke, 3 (1.7%) patients had a peripheral embolism, and 8 (4.7%) patients presented with a documented atrial arrhythmia. There were no significant differences in clinical outcomes among the devices. Transesophageal echocardiography follow-up revealed higher closure rates with GSO (92.6%) and BioSTAR (93.7%) compared with HELEX (74.2%; P = 0.031 and P = 0.034, respectively) and APO (76.4%; P = 0.036 and P = 0.041, respectively). Conclusions: The GSO and BioSTAR showed better closure rates than HELEX and APO at 4 months. PFO closure is a safe procedure with a low rate of clinical events at follow-up.
引用
收藏
页码:639 / 646
页数:8
相关论文
共 24 条
[1]   Meta-Analysis of Transcatheter Closure Versus Medical Therapy for Patent Foramen Ovale in Prevention of Recurrent Neurological Events After Presumed Paradoxical Embolism [J].
Agarwal, Shikhar ;
Bajaj, Navkaranbir Singh ;
Kumbhani, Dharam J. ;
Tuzcu, E. Murat ;
Kapadia, Samir R. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (07) :777-789
[2]  
Alaeddini Jamshid, 2006, J Invasive Cardiol, V18, P365
[3]   Atrial fibrillation following device closure of patent foramen ovale [J].
Burow, Annika ;
Schwerzmann, Markus ;
Wallmann, Dieter ;
Tanner, Hildegard ;
Sakata, Takao ;
Windecker, Stephan ;
Meier, Bernhard ;
Delacretaz, Etienne .
CARDIOLOGY, 2008, 111 (01) :47-50
[4]   Residual Shunt after Patent Foramen Ovale Closure: Preliminary Results from Italian Patent Foramen Ovale Survey [J].
Caputi, Luigi ;
Butera, Gianfranco ;
Anzola, Gian Paolo ;
Carminati, Mario ;
Carriero, Maria Rita ;
Chessa, Massimo ;
Onorato, Eustaquio ;
Rigatelli, Gianluca ;
Sangiorgi, Giuseppe ;
Santoro, Gennaro ;
Spadoni, Isabella ;
Ussia, Gian Paolo ;
Vigna, Carlo ;
Zanchetta, Mario ;
Parati, Eugenio .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (07) :E219-E226
[5]   Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke [J].
Carroll, John D. ;
Saver, Jeffrey L. ;
Thaler, David E. ;
Smalling, Richard W. ;
Berry, Scott ;
MacDonald, Lee A. ;
Marks, David S. ;
Tirschwell, David L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (12) :1092-1100
[6]   Life-threatening impending paradoxical embolus caught "red-handed": Successful management by multidisciplinary team approach [J].
Choong, Cliff K. ;
Calvert, Patrick A. ;
Falter, Florian ;
Mathur, Raj ;
Appleton, Derek ;
Wells, Francis C. ;
Schofield, Peter M. ;
Crawford, Robin .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 136 (02) :527-528
[7]   Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale [J].
Furlan, Anthony J. ;
Reisman, Mark ;
Massaro, Joseph ;
Mauri, Laura ;
Adams, Harold ;
Albers, Gregory W. ;
Felberg, Robert ;
Herrmann, Howard ;
Kar, Saibal ;
Landzberg, Michael ;
Raizner, Albert ;
Wechsler, Lawrence .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (11) :991-999
[8]   Patent Foramen Ovale: When Is Intervention Warranted? [J].
Landzberg, Michael J. ;
Khairy, Paul .
CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (07) :890-892
[9]   PREVALENCE OF PATENT FORAMEN OVALE IN PATIENTS WITH STROKE [J].
LECHAT, P ;
MAS, JL ;
LASCAULT, G ;
LORON, P ;
THEARD, M ;
KLIMCZAC, M ;
DROBINSKI, G ;
THOMAS, D ;
GROSGOGEAT, Y .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (18) :1148-1152
[10]   Paradoxical embolus illustrating speed of action of recombinant tissue plasminogen activator in massive pulmonary embolism [J].
Madani, H. ;
Ransom, P. A. .
EMERGENCY MEDICINE JOURNAL, 2007, 24 (06) :441-441